|Articles|May 15, 2002
- BioPharm International-05-01-2002
- Volume 15
- Issue 5
Freezing Bulk-Scale Biopharmaceuticals Using Common Techniques ? and the Magnitude of Freeze-Concentration
by Serena Donnelly Webb, David F. Sesin, Aimee C. Kincaid, Jonathan N. Webb, and Timothy G. Hughes, Integrated Biosystems, Inc. Large-scale freezing and thawing is commonly used in biopharmaceutical manufacturing but is not well understood. Freeze-thaw variations can exist within or between batches, and nonuniform processes raise serious validation concerns.
Advertisement
Articles in this issue
over 23 years ago
Info+over 23 years ago
Analytical Advances: Strategies in Clarifying Mammalian Culturesover 23 years ago
Analytical Advances: Using Image Informatics - Focusing Proteomicsover 23 years ago
The Not-So-Sure Thingover 23 years ago
Washington Report: Vaccine Shortages put Spotlight on Productionover 23 years ago
Guest Editorial: Validation Bingoover 23 years ago
Travel Notes: Yes, Virginia, There is Biotech in the CommonwealthNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
2
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
3
Developing Next-Gen Cell Lines Using Targeted Integration
4
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
5
